Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Why Is Cancer Focused Tempest Therapeutics Stock Trading Higher On Thursday?
October 10, 2024
Tickers
NEWS
RHHBY
TPST
Tags
Movers
why it's moving
Briefs
From
Benzinga
Nano-Cap Bio-Path Takes Plunge In Weight Loss Race, Initiates Obesity Program With Drug Candidate Under Development For Blood Cancer
October 08, 2024
Tickers
ABBV
BPTH
NEWS
RHHBY
Tags
Benzinga
Market News
BPTH
From
Benzinga
Scholar Rock's Muscle Wasting Drug Excels In Pivotal Trial, Plans FDA Submission Next Year
October 07, 2024
Tickers
BIIB
NEWS
RHHBY
SRRK
Tags
why it's moving
News
Briefs
From
Benzinga
2 Artificial Intelligence Stocks That Could Deliver Explosive Gains
October 07, 2024
Tickers
RHHBY
RXRX
SNY
SOUN
Tags
STLA
Market News
SOUN
From
Motley Fool
Economist Justin Wolfers Points To Obesity Rate Decline As Ozempic And Wegovy Spur Historic Shift In Fight Against Obesity — Has US Reached A Turning Point?
October 06, 2024
Tickers
LLY
NEWS
NVO
RHHBY
Tags
Equities
Health Care
Market News
From
Benzinga
3 Top Stocks That Could Still Rocket Higher in 2024
October 04, 2024
Tickers
BBIO
PFE
PTCT
RHHBY
Tags
Market News
BBIO
PFE
From
Motley Fool
Roche Fast-Tracks Obesity Drug Development, Eyes Over $3B Sales Potential
September 30, 2024
Tickers
LLY
NEWS
NVO
RHHBY
Tags
Market News
Benzinga
NVO
From
Benzinga
Roche's Antiviral Drug Reduces Transmission Of Influenza Viruses, Late-Stage Study Shows
September 19, 2024
Tickers
NEWS
RHHBY
Tags
Top Stories
Market News
Stories That Matter
From
Benzinga
1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)
September 17, 2024
Tickers
ALT
AMZN
HIMS
LLY
Tags
TDOC
ALT
AMZN
From
Motley Fool
Back-To-Back FDA Approvals For Roche's Two Under-The-Skin Injections
September 16, 2024
Tickers
NEWS
RHHBY
Tags
News
Briefs
General
From
Benzinga
Viking Therapeutics: A Bad Result for Roche's Weight-Management Pill Is Great News for Oral VK2735
September 13, 2024
Tickers
RHHBY
VKTX
Tags
VKTX
Recent Press Releases
RHHBY
From
Motley Fool
Why Roche Holdings Stock Withered on Wednesday
September 11, 2024
Tickers
LLY
NVO
RHHBY
Tags
RHHBY
Recent Press Releases
NVO
From
Motley Fool
Fulcrum Therapeutics Upgraded: BofA Debates Pivotal Study Success For Losmapimod In Rare Genetic Muscle Disease
September 09, 2024
Tickers
FULC
NEWS
RHHBY
RNA
Tags
Analyst Ratings
Market News
Trading Ideas
From
Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
September 09, 2024
Tickers
AZN
BMY
ELVN
NEWS
Tags
Market News
TAK
Benzinga
From
Benzinga
Moderna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales
August 29, 2024
Tickers
BNTX
MRK
MRNA
NEWS
Tags
Health Care
AI Generated
BNTX
From
Benzinga
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
August 26, 2024
Tickers
ABT
BVNKF
BVNRY
DGX
Tags
Top Stories
BVNRY
ABT
From
Benzinga
Novo Nordisk and Eli Lilly Could Have a Big Rival in the GLP-1 Market in a Few Years
August 18, 2024
Tickers
LLY
NVO
RHHBY
Tags
RHHBY
Recent Press Releases
NVO
From
Motley Fool
Roche Misses Out On Weight-Loss Blockbuster Drug, Now Playing Catch-Up In Booming Market
August 16, 2024
Tickers
LLY
NEWS
NVO
RHHBY
Tags
Briefs
News
General
From
Benzinga
Why Is Small-Cap Tempest Therapeutics Stock Trading Higher On Thursday?
August 15, 2024
Tickers
NEWS
RHHBY
TPST
Tags
Benzinga
FDA
Market News
From
Benzinga
Prediction: This Company Will Disrupt Eli Lilly and Novo Nordisk in the Weight Loss Market (Hint: It's Not Pfizer)
August 15, 2024
Tickers
LLY
NVO
RHHBY
Tags
Market News
RHHBY
Recent Press Releases
From
Motley Fool
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
August 13, 2024
Tickers
ABBV
BMY
NEWS
RHHBY
Tags
Market News
SYRS
Benzinga
From
Benzinga
Merck Stops Lung Cancer Study For Keytruda Combo Due To Ineffective Results, Side Effects
August 08, 2024
Tickers
MRK
NEWS
RHHBY
Tags
Benzinga
MRK
Market News
From
Benzinga
Here's Why Eli Lilly Stock Dropped 12% Last Month
August 08, 2024
Tickers
AMGN
LLY
NVO
PFE
Tags
PFE
AMGN
NVO
From
Motley Fool
Roche Considers Selling Cancer Data Specialist Flatiron Health Business, Highlights Challenges With Start-Up Acquisitions
August 07, 2024
Tickers
C
GOOG
GOOGL
NEWS
Tags
C
Market News
Benzinga
From
Benzinga
Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus
August 05, 2024
Tickers
AGEN
BMY
MRK
NEWS
Tags
Large Cap
Biotech
Contracts
From
Benzinga
Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
August 02, 2024
Tickers
ALT
LLY
NVO
PFE
Tags
Market News
PFE
VKTX
From
Motley Fool
Weight Loss Drug Stocks Just Took a Hit. Should You Buy the Stock That Caused It?
July 29, 2024
Tickers
LLY
NVO
RHHBY
Tags
Recent Press Releases
RHHBY
NVO
From
Motley Fool
Novo Nordisk's Stock Dips In Pre-Market Despite Winning UK's Approval Of Weight Loss Drug: What's Going On
July 24, 2024
Tickers
LLY
NEWS
NVO
PFE
Tags
Biotech
Health Care
wegovy
From
Benzinga
Look Out, Eli Lilly and Novo Nordisk: Could Roche Be the Obesity Drug Stock to Really Watch?
July 23, 2024
Tickers
LLY
NVO
RHHBY
Tags
Market News
LLY
NVO
From
Motley Fool
Oral Weight Loss Drugs Vs. Injections - Pills Are Promising Yet Challenging Frontier
July 22, 2024
Tickers
LLY
NEWS
NVO
PFE
Tags
Stories That Matter
News
Briefs
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.